Not exact matches
Multiple ultrasounds will move
cells in the brain around and also
affect future generations of your family.
Multiple myeloma is a cancer that
affects plasma
cells.
The new work, published today in
Cell Reports, finds that the protein ADR - 1 binds to messenger ribonucleic acid, or mRNA, and then enhances RNA editing, a process that allows a gene to be present as
multiple mRNAs that can then each
affect gene expression differently.
Researchers at MIT have now shown that they can use a new type of measurement to predict how drugs will
affect cancer
cells taken from
multiple - myeloma patients.
In the 1990s the U.S. Food and Drug Administration approved its use in the treatment of both
multiple myeloma (a form of cancer that
affects plasma
cells) and the complications of leprosy.
We use
multiple mouse models combined with in vitro approaches to address the pleiotropic functions of these cytokines which
affect both the epithelial cancer
cells and the inflammatory infiltrate within tumors.
Multiple sclerosis (MS) is among the most common neurological diseases in young adults,
affecting 350 000 individuals in the United States and 2 million worldwide.1 Prevailing thought is that MS is an autoimmune disorder whereby an unknown agent or agents triggers a T
cell — mediated inflammatory attack, causing demyelination of central nervous system tissue.2
The actin cytoskeleton and cytotoxic T lymphocytes: evidence for
multiple roles that could
affect granule exocytosis - dependent target
cell killing.
This is in accordance with previous reports that decitabine and 5 - azacytidine produce a marked synergistic effect in combination with suberoylanilide hydroxamic acid and romidepsin in T - lymphoma
cell lines by modulating
cell cycle arrest and apoptosis.26, 27 As a mechanism of action, KMT2D mutations of B - lymphoma
cells promote malignant outgrowth by perturbing methylation of H3K4 that
affect the JAK - STAT, Toll - like receptor, or B -
cell receptor pathway.28, 29 Here our study indicated that dual treatment with chidamide and decitabine enhanced the interaction of KMT2D with the transcription factor PU.1, thereby inactivating the H3K4me - associated signaling pathway MAPK, which is constitutively activated in T -
cell lymphoma.13, 30,31 The transcription factor PU.1 is involved in the development of all hematopoietic lineages32 and regulates lymphoid
cell growth and transformation.33 Aberrant PU.1 expression promotes acute myeloid leukemia and is related to the pathogenesis of
multiple myeloma via the MAPK pathway.34, 35 On the other hand, PU.1 is also shown to interact with chromatin remodeler and DNA methyltransferease to control hematopoiesis and suppress leukemia.36 Our data thus suggested that the combined action of chidamide and decitabine may interfere with the differentiation and / or viability of PTCL - NOS through a PU.1 - dependent gene expression program.
As you know, embryonic stem
cells have the potential to be used to treat and better understand deadly and disabling diseases and conditions that
affect more than 100 million Americans, such as cancer, heart disease, diabetes, Parkinson's, Alzheimer's,
multiple sclerosis, spinal cord injury, and many others.
Multiple myeloma is a rare, malignant plasma
cell cancer
affecting the bone marrow and other blood producing organs.
Any time the seizures are too frequent they can cause a process call «kindling» in which further (non-epileptic) brain
cells are
affected adversely leading to the next set of seizures occurring even sooner or lasting longer.8 Eventually some dogs have very frequent clusters of seizures happening
multiple time in one day, or go into a continuous seizure (status epilepticus) which is life threatening and can lead to permanent brain damage or death.
When a cat develops lymphoma, the lymphocyte, which is a
cell of the normal immune system, becomes cancerous and can
affect multiple areas of the body.